How many clinical trials are studying Apatinib?

6 recruiting trials in our tracked data involve Apatinib.

What conditions is Apatinib being studied for?

In our tracked recruiting trials, Apatinib is being studied in trials for Breast Cancer, Advanced Breast Cancer, Breast Neoplasm.

Recruiting trials

Conditions studied

US states with sites

Countries

Phase 2 4 Phase 3 1 Not applicable 1

Condition	Trials
Breast Cancer · Apatinib for Breast Cancer	5
Advanced Breast Cancer	2
Breast Neoplasm	2
HER2-negative Breast Cancer	2
Hormone Receptor Positive Tumor	2
Breast Tumors	1
Early-stage Breast Cancer	1
HER2-negative Breast Cancer Brain Metastases	1
HER2-positive Breast Cancer	1
HR+/HER2- Breast Cancer	1
Hormone Receptor Negative Tumor	1
Hypertension	1
Intrahepatic Cholangiocarcinoma (Icc)	1
Locally Advanced Breast Cancer	1
Lung cancer	1

Adebrelimab Plus Apatinib and Etoposide for the Treatment of HER2-Negative Breast Cancer Brain Metastasis
NCT06418594 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
Adjuvant Therapy for High-Risk Intrahepatic Cholangiocarcinoma: A Real-World Study
NCT07640048 · Phase: Not specified · Ages: 18 Years and older · Sex: All (male and female) · 2 locations
Apatinib Combined With cdk4/6i in First-line Treatment for HR+/HER2- SNF4 Subtype Breast Cancer
NCT06447623 · Phase: Phase 3 · Ages: 18 Years to 75 Years · Sex: Female · 1 location
Fudan University Shanghai Cancer Center Breast Cancer Precision Platform Series Study- Neoadjuvant Therapy
NCT05582499 · Phase: Phase 2 · Ages: 18 Years to 70 Years · Sex: Female · 1 location
SNF Platform Study of HR+/ HER2-advanced Breast Cancer
NCT05594095 · Phase: Phase 2 · Ages: 18 Years and older · Sex: Female · 1 location
Study of Camrelizumab Plus Apatinib and Chemotherapy as Neoadjuvant Therapy in Participants With Triple Negative Breast Cancer (TNBC)
NCT05447702 · Phase: Phase 2 · Ages: 18 Years to 75 Years · Sex: Female · 1 location